Mean (95% CI) and standard deviation of VAS Score (mm) before & after intervention between two group during 1-houre standing. Intervention: using footrest with/without changing arm... by Saeedeh Abbasi (9423189)

Subjects:

Data. by Saeedeh Abbasi (9423189)

Subjects:

Co-Contraction index of right and left gluteus medius activity (MVC%) during 60 minutes standing (time- condition) between two groups (A: used the footrest intermittently, B: used... by Saeedeh Abbasi (9423189)

Subjects:

Example of a participant using the elevated surface (20 cm) during the intermittent footrest use (A) and the intermittent footrest use with arm flexion, hands crossed on the clavic... by Saeedeh Abbasi (9423189)

Subjects:

VAS score (mm) before & after intervention between two group (A: used the footrest intermittently, B: used the footrest with change arm positions) every 15 minutes during 60 minute... by Saeedeh Abbasi (9423189)

Subjects:

Mean (95% CI) and standard deviation of Co-Contraction index of right and left gluteus medius (MVC%) during 60 minutes standing between two groups. by Saeedeh Abbasi (9423189)

Subjects:

RTA408 significantly reduces RGCs loss in glaucoma. by Hongmei Qian (538647)

Subjects:

The impact of various treatment regimens on SW480 tumour reduction in BALB/C nude mice is evident. by Zhi Xuan Low (19270163)

Subjects:

Proposed metabolic pathways related to vanadate reduction and alanine production by <i>T</i>. <i>mesophilus</i> VROV1. by Bokyung Kim (622579)

Subjects:

The wound appearance of different groups during the period of study (a) and the percentage of wound reduction in treated groups on different days (b). by Omid Mehrpour (9385929)

Subjects:

Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

Subjects:

Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

Subjects:

Study-related adverse events. by Benjamin R. Lewis (22279166)

Subjects:

Study flow chart. by Benjamin R. Lewis (22279166)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Study CONSORT diagram. by Benjamin R. Lewis (22279166)

Subjects:

Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

<i>son</i> reduction decreases T cell numbers. by Rebecca L. Belmonte (8384103)